[HIV-associated Neuropathies]
Overview
Authors
Affiliations
Human immunodeficiency virus (HIV)-associated polyneuropathy has become the most common neurological complication of HIV infection and is one of the main risk factors for development of a neuropathy worldwide. Therefore HIV should always be considered as an underlying cause in patients with neuropathy. Many types of peripheral neuropathies are seen in HIV infection depending on the stage of infection. The inflammatory demyelinating neuropathies both acute (Guillain-Barré syndrome, GBS) and chronic (chronic inflammatory demyelinating neuropathy, CIDP) occur mainly at the time of seroconversion or early in the course of the disease while syndromes associated with opportunistic infections like CMV (i.e. polyradiculoneuropathy) occur in the late phase of HIV infection and are related to the loss of immune function. Distal symmetrical polyneuropathy (DSP) is the most common neuropathy in HIV-infected patients. We review the clinical manifestations, epidemiology, clinical diagnostics, pathophysiology and management strategies for HIV-associated polyneuropathies.
A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients.
Moodley K, Bill P, Patel V Neurol Neuroimmunol Neuroinflamm. 2017; 4(2):e315.
PMID: 28054000 PMC: 5182055. DOI: 10.1212/NXI.0000000000000315.
The HIV-1 transgenic rat model of neuroHIV.
Vigorito M, Connaghan K, Chang S Brain Behav Immun. 2015; 48:336-49.
PMID: 25733103 PMC: 4753047. DOI: 10.1016/j.bbi.2015.02.020.
Acute hemiplegia as a rare presentation of infantile Guillain-Barre syndrome.
Al-Mendalawi M Saudi Med J. 2014; 35(11):1419.
PMID: 25399226 PMC: 4362134.
Influence of short-term glucocorticoid therapy on regulatory T cells in vivo.
Sbiera S, Dexneit T, Reichardt S, Michel K, van den Brandt J, Schmull S PLoS One. 2011; 6(9):e24345.
PMID: 21912688 PMC: 3166315. DOI: 10.1371/journal.pone.0024345.